Pauls Dietrich John 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 26, 2019
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2019-06-24+264,000→ 264,000 totalExercise: $4.60Exp: 2029-06-23→ Common Shares (264,000 underlying)
Holdings
- 29,804
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests in eight equal quarterly installments over two years.